Keyphrases
Multiple Mechanisms
100%
Mammalian Target of Rapamycin (mTOR)
100%
Vincristine Resistance
100%
Glycolytic Rate
100%
Rapamycin
25%
Phosphorylation
16%
Akt Activation
16%
Via Resistance
16%
Clinical Trials
8%
Phosphoinositide 3-kinase (PI3K)
8%
Akt Phosphorylation
8%
Specific Inhibitor
8%
Deregulation
8%
Oncology
8%
Metabolic Control
8%
Oncogenesis
8%
Major Contributor
8%
Protein Synthesis
8%
Constitutively Active
8%
Dominant Negative
8%
Cellular Metabolism
8%
Prolonged Exposure
8%
Chemotherapy Resistance
8%
Minor Effect
8%
AKT/mammalian Target of Rapamycin
8%
Antimicrotubule Agents
8%
Rapamycin Analogs
8%
Thioglucose
8%
Growth Factor Withdrawal
8%
Resistance to Cancer Therapy
8%
Hexokinase Inhibitor
8%
Neuroscience
Mammalian Target of Rapamycin
100%
Vincristine
100%
Sirolimus
30%
Immunosuppressant
7%
Protein Biosynthesis
7%
Hexokinase
7%
Phosphoinositide 3-Kinase
7%
Antimicrotubule Agent
7%
Carcinogenesis
7%
Growth Factor
7%
Metabolic Pathway
7%
Immunosuppressive Drug
7%
Biochemistry, Genetics and Molecular Biology
Mechanistic Target of Rapamycin
100%
Clinical Trial
7%
Protein Biosynthesis
7%
Metabolic Regulation
7%
Cell Metabolism
7%
Growth Factor
7%
Carcinogenesis
7%
Phosphoinositide 3-Kinase
7%
Hexokinase
7%